ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Eterna Therapeutics Inc

Eterna Therapeutics Inc (ERNA)

0.249
0.0036
(1.47%)
終了 12月26日 6:00AM
0.2491
0.0001
(0.04%)
取引時間後: 6:31AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
0.249
買値
0.2491
売値
0.254
出来高
124,191
0.2455 日の範囲 0.259499
0.2212 52 週間の範囲 2.625
時価総額
前日終値
0.2454
始値
0.255
最終取引時間
財務取引量
US$ 31,494
VWAP
0.253595
平均取引量 (3 か月)
733,087
発行済株式数
51,374,713
配当利回り
-
PER
-0.59
1 株当たり利益 (EPS)
-0.42
歳入
68k
純利益
-21.68M

Eterna Therapeutics Inc について

Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indicati... Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Television Broadcast Station
ウェブサイト
本社
Wilmington, Delaware, USA
設立
2022
Eterna Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker ERNA. The last closing price for Eterna Therapeutics was US$0.25. Over the last year, Eterna Therapeutics shares have traded in a share price range of US$ 0.2212 to US$ 2.625.

Eterna Therapeutics currently has 51,374,713 shares in issue. The market capitalisation of Eterna Therapeutics is US$12.61 million. Eterna Therapeutics has a price to earnings ratio (PE ratio) of -0.59.

ERNA 最新ニュース

Eterna Therapeutics Launches Research to Evaluate its Lead Induced Mesenchymal Stem Cell Therapy Candidate’s (ERNA-101) Ability to Induce and Modulate Antitumor Immunity in Ovarian Cancer and Breast Cancer Models

CAMBRIDGE, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA) today announced it will investigate the ability of its lead iMSC-based cell therapy (ERNA-101) to induce...

Eterna Therapeutics Announces Up to $1 Million Stock Repurchase Program

CAMBRIDGE, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics, Inc. (Nasdaq: ERNA), a leader in cell therapies, today announced that its Board of Directors has authorized a stock...

Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing

CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) announced today that it has regained compliance with Nasdaq for continued...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.0233-8.556738890930.27230.30.22124050160.2540777CS
4-0.2708-52.09696036940.51980.5250.221220468320.31151618CS
12-0.781-75.82524271841.031.250.22127330870.35449906CS
26-1.661-86.96335078531.912.6250.22123497540.38967784CS
52-1.591-86.46739130431.842.6250.22121828390.42769562CS
156-3.951-94.07142857144.27.150.22121088101.23375634CS
260-3.951-94.07142857144.27.150.22121088101.23375634CS

ERNA - Frequently Asked Questions (FAQ)

What is the current Eterna Therapeutics share price?
The current share price of Eterna Therapeutics is US$ 0.249
How many Eterna Therapeutics shares are in issue?
Eterna Therapeutics has 51,374,713 shares in issue
What is the market cap of Eterna Therapeutics?
The market capitalisation of Eterna Therapeutics is USD 12.61M
What is the 1 year trading range for Eterna Therapeutics share price?
Eterna Therapeutics has traded in the range of US$ 0.2212 to US$ 2.625 during the past year
What is the PE ratio of Eterna Therapeutics?
The price to earnings ratio of Eterna Therapeutics is -0.59
What is the cash to sales ratio of Eterna Therapeutics?
The cash to sales ratio of Eterna Therapeutics is 192.31
What is the reporting currency for Eterna Therapeutics?
Eterna Therapeutics reports financial results in USD
What is the latest annual turnover for Eterna Therapeutics?
The latest annual turnover of Eterna Therapeutics is USD 68k
What is the latest annual profit for Eterna Therapeutics?
The latest annual profit of Eterna Therapeutics is USD -21.68M
What is the registered address of Eterna Therapeutics?
The registered address for Eterna Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Eterna Therapeutics website address?
The website address for Eterna Therapeutics is eternatx.com
Which industry sector does Eterna Therapeutics operate in?
Eterna Therapeutics operates in the TELEVISION BROADCAST STATION sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BAOSBaosheng Media Group Holdings Ltd
US$ 7.10
(310.40%)
58.74M
HOURHour Loop Inc
US$ 4.40
(207.69%)
97.42M
GTIGraphjet Technology
US$ 0.61
(168.72%)
265.48M
CREVCarbon Revolution Public Ltd
US$ 9.16
(135.48%)
26.95M
AVGRAvinger Inc
US$ 1.45
(125.72%)
107.53M
SLGLSol Gel Technologies Ltd
US$ 0.9798
(-40.62%)
3.07M
DRCTDirect Digital Holdings Inc
US$ 3.71
(-32.55%)
23.82M
CHEKCheck Cap Ltd
US$ 1.55
(-31.11%)
3.49M
SYTASiyata Mobile Inc
US$ 0.5178
(-30.83%)
2.63M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
US$ 15.47
(-30.38%)
147.98k
SVMHSRIVARU Holding Ltd
US$ 0.0338
(20.71%)
280.27M
GTIGraphjet Technology
US$ 0.61
(168.72%)
265.48M
LITMSnow Lake Resources Ltd
US$ 0.5849
(52.84%)
181.22M
LCIDLucid Group Inc
US$ 3.20
(3.23%)
108.75M
RGTIRigetti Computing Inc
US$ 11.35
(3.56%)
108.38M

ERNA Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock